
501 - 1000 employés
Fondée en 2001
🏥 Santé
💼 Conseil
🧬 Biotechnologie
Healthcare • Consulting • Biotechnology
Asklepios BioPharmaceutical, Inc. (AskBio) est une entreprise de thérapie génique de premier plan, se concentrant sur le développement de traitements pour les maladies génétiques débilitantes. Entièrement détenue par Bayer AG, AskBio se spécialise dans les thérapies géniques à base de virus adéno-associé (AAV), visant à traiter diverses maladies neuromusculaires, du système nerveux central, cardiovasculaires, et métaboliques. L'un de leurs développements notables est l'AB-1003 (LION-101), qui a reçu des désignations de maladie pédiatrique rare et de médicament orphelin de la FDA pour le traitement de la dystrophie musculaire des ceintures de type 2I/R9. AskBio se consacre à l'avancement de la médecine génétique, avec un portefeuille solide de programmes cliniques conçus pour apporter des options thérapeutiques innovantes aux patients du monde entier.
🕒 il y a 7 mois
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

501 - 1000 employés
Fondée en 2001
🏥 Santé
💼 Conseil
🧬 Biotechnologie
Healthcare • Consulting • Biotechnology
Asklepios BioPharmaceutical, Inc. (AskBio) est une entreprise de thérapie génique de premier plan, se concentrant sur le développement de traitements pour les maladies génétiques débilitantes. Entièrement détenue par Bayer AG, AskBio se spécialise dans les thérapies géniques à base de virus adéno-associé (AAV), visant à traiter diverses maladies neuromusculaires, du système nerveux central, cardiovasculaires, et métaboliques. L'un de leurs développements notables est l'AB-1003 (LION-101), qui a reçu des désignations de maladie pédiatrique rare et de médicament orphelin de la FDA pour le traitement de la dystrophie musculaire des ceintures de type 2I/R9. AskBio se consacre à l'avancement de la médecine génétique, avec un portefeuille solide de programmes cliniques conçus pour apporter des options thérapeutiques innovantes aux patients du monde entier.
• Drive the overall clinical development strategy in alignment with function, program team and timelines for the GDNF gene therapy program across Phase 1–3 with specific focus on movement disorders • Serve as a Parkinson’s clinical expert in state-of-the-art, randomized, double-blind clinical trials with emphasis on maintenance of the blinding status of the trial • Serve as the medical lead for clinical trial design, protocol development, and endpoint strategy for movement disorders indications • Provide medical oversight for clinical trials, ensuring patient safety, data integrity, and regulatory compliance • Lead clinical risk–benefit assessments, including safety signal evaluation, dose escalation decisions, and go/no-go recommendations • Authoring support for regulatory interactions, including FDA meetings, briefing documents, and inspection readiness activities • Oversee long-term follow-up (LTFU) strategies required for gene therapy products, including delayed safety monitoring and post-treatment commitments • Guide and mentor Medical Directors and other clinical team members; contribute to clinical capability building • Partner with Clinical Operations, Biostatistics, Regulatory, and CMC to ensure integrated program execution • Present clinical strategy and data to senior leadership, governance committees, and external stakeholders • Ensure a culture of inspection readiness, quality, and continuous improvement across the clinical organization • Support the strategic vision for clinical development for the GDNF program and contribute to broader organizational clinical strategy as appropriate • Foster and maintain strong relationships with key opinion leaders (KOLs), investigators, and external scientific and clinical stakeholders • Oversee the integration of clinical development activities with cross-functional partners, including Regulatory, CMC/Manufacturing, Commercial, and Research, to ensure seamless program advancement • Represent the organization as a clinical and scientific leader in high-level industry forums, scientific meetings, advisory boards, and conferences
• MD from an accredited U.S. medical school or equivalent international medical degree with 6+ years relevant clinical experience with Movement Disorders patients • Completion of clinical training with board certification or eligibility in Neurology or a closely related specialty with movement disorders specialization and clinical experience • Minimum of two years of industry experience or related experience in clinical development within the pharmaceutical, biotechnology, medical device, or CRO/CDMO environment • Demonstrated leadership in the design and execution of clinical trials across multiple phases, including oversight of clinical monitoring activities • Proven experience supporting FDA or global health authority inspections, audits, or formal inspection readiness initiatives • Working knowledge of GCP, regulatory requirements, and trial quality management systems • Ability to independently lead clinical programs and make program-level medical decisions in a regulated development environment • Strong strategic leadership and cross-functional influence. • Ability to support FDA inspection readiness activities, including review of critical trial documentation, monitoring outputs, and CAPAs • Expertise in risk-based monitoring and clinical trial quality oversight • Strong analytical judgment applied to complex clinical and safety issues • Excellent communication and executive presentation skills • Ability to operate effectively in a fast-paced, evolving biotech environment • Proven track record of successful clinical program leadership , including advancing programs through critical development milestones • Exceptional strategic and operational planning skills , with the ability to translate long-term vision into executable clinical plans • Strong leadership presence with the ability to influence, inspire, and align cross-functional teams • Established professional network within the gene therapy and/or CNS development community • Understanding of market dynamics, competitive landscape, and evolving trends relevant to gene therapy and movement disorders.
• Health insurance • 401(k) matching • Flexible work hours • Paid time off • Professional development opportunities
Postuler Maintenant🕒 il y a 7 mois
Medical Director specializing in gene therapy for movement disorders at AskBio, overseeing clinical development and ensuring compliance in Phase 1–3 trials.
🇺🇸 États-Unis – Télétravail
💰 €2 656 252 Grant - Asklepios BioPharmaceutical en 2020-09
⏰ Temps Plein
🔴 Expert
👨⚕️ Directeur Médical
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 7 mois
Medical Director providing clinical governance and oversight for aesthetic practices within Georgia. Ensures compliance with local regulations and facilitates operational partnerships across multiple sites.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 7 mois
Medical Director overseeing utilization management reviews for Florida Blue. Collaborating with teams and ensuring compliance with medical necessity standards.
🇺🇸 États-Unis – Télétravail
💵 $224 000 - $364 000 / an
⏰ Temps Plein
🔴 Expert
👨⚕️ Directeur Médical
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 7 mois
Medical Director overseeing aesthetic procedures remotely for independent practices while ensuring compliance with regulations in the US. Responsible for clinical governance and multi-site oversight.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 7 mois
Medical Director providing leadership for clinical trial studies. Collaborating with global teams to ensure study quality and compliance in groundbreaking research.
🗣️🇺🇸🇬🇧 Anglais requis